Village Farms International, Inc. Q2 FY2024 Earnings Call

Good morning, ladies and gentlemen. Welcome to Village Farm International’s Second Quarter 2024 Financial Results Conference Call. This morning, Village Farms issued a news release reporting its financial results for the second quarter ended June 30, 2024. That news release, along with the company's financial statements, are available on the company's website at villagefarms.com, under the investors heading. Please note that today’s call is being broadcast live over the internet and will be archived for replay, both by telephone and via the internet, beginning approximately one hour following completion of the call. Details of how to access the replays are available in today’s news release. Before we begin, let me remind you that forward-looking statements may be made today during or after the formal part of this conference call. Certain material assumptions were applied in providing these statements, which are beyond our control. These statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied in forward-looking statements. A summary of these underlying assumptions, risks and uncertainties is contained in the company’s various securities filings with the SEC and Canadian regulators, including its Form 10-K and MD&A for the year ended December 31, 2023, and 10-Q for the quarter ended June 30, 2024, which will be available on EDGAR and SEDAR. Those forward-looking statements are made as of today’s date and, except as required by applicable securities laws, we undertake no obligation to publicly update or revise any such statements. I would now like to turn the call over to Michael DeGiglio, Chief Executive Officer of Village Farms International. Please go ahead, Mr. DeGiglio.

Thank you, Tonya, good morning and thank you for joining us today. With me are Steve Ruffini, Chief Financial Officer; Ann Gillin Lefever, Chief Operating Officer; and Patti Smith, Corporate Controller. So, Q2 is another strong quarter for Village Farms with record consolidated sales, driven by Canadian cannabis, which reported a new quarterly sales record, and fresh produce, which tied its second highest quarterly sales in the last five years. I'm very pleased with the continued growth in Canadian cannabis, which is broad based across our brands, form factors and geographies. Total net sales grew 45% year-over-year, all organically without acquisitions to $56 million. Branded retail sales grew 35%, and we were once again profitable with positive cash flow from operations of CAD7.2 million. In Q1, we noted that we had the fastest growing market share of the top five Canadian LPs. In Q2, we were the only top five producer to grow share, the only one. We are now less than two percentage points from the number one market share rank in Canada. Importantly, our market growth is diversified across leading brands, multiple cannabis form factors, consumer segments and geographies. So, let me give you a few examples which show the depth of our business model. We are the fastest growing producer in pre-rolls year-to-date. In just the last 12 months, with investment in innovation and a renewed focus on assortment and pricing, our brilliant team has expanded our share in the national pre-roll market by just under three percentage points to nearly 8% of the market. Our game-changing Hi-Def pre-rolls remain a true innovation in the category and we are also gaining share through our focus on quality inputs across all of our pre-rolls. Super Toast, our milled flower brand, continues its outstanding performance despite the milled category being very competitive with a well-entrenched leader. It's the third fastest growing brand nationally despite selling in just four provinces and growth is accelerating. We have a 20% share of the milled category nationally, 25% in Ontario, and that's despite launching just one year ago. We have a 94% repeat purchase rate among our consumers. In May, Super Toast Sergeant Pineapple took over as the top milled SKU in Ontario. This is a great example of extending our quality into new categories that resonate with our consumers. We are also building share across different consumer price points. In the Premium segment, our Soar brand continues to excel. Strong performance in flower is being complemented by innovation in the infused pre-roll category. Soar's Pineapple God is the fourth best-selling premium SKU nationally. Finally, we continue to innovate in flower with new strains to delight our consumers. We had the number one flower products nationally in both Q1 and Q2 of this year. Our Fraser Valley's Donny Burger and Pure Laine Big Pleasures were in that category. We recently launched three new cultivars in British Columbia under our grower-led trials by Pure Sunfarms strategy with its unique limited release small batch offerings. In addition, our new in-house breed, Pure Sunfarms Kush God strain derived from two Village Farms iconic parent strains, Pink Kush and Pineapple God, and our new Pure Sunfarms Gold Face strain have each added meaningfully to market share with demand outstripping initial expectations. Another important metric is the geographical ranking, which tells us our products are resonating across Canada's many consumer preferences. We are strengthening our number one and two positions in Ontario and Quebec. We are now tied for the number two rank in British Columbia, moving up two positions in the last year, and in Alberta, we improved our rank to fourth, that's up four positions from eight this time last year. And we are also growing our international export business. Q2 was another good quarter with solid contributions from Germany and the United Kingdom, as these countries ramp up and become an increasingly bigger proportion of our export sales. Notably in Germany, we have seen higher demand following the regulatory change there in April. Sales to Australia overall are growing. While those reported as international sales decreased from Q2 last year, total Australian sales, including those that get reported as non-branded due to the nature of the customer, grew fourfold from Q2 last year. Our flower strategy has proven successful in Canada and is now doing the same internationally. In the Netherlands, we are just months away from the start of production for our Dutch consumers. The program recently completed its startup phase, expanding the number of municipalities in the Netherlands in which legal cannabis can be sold in coffee shops from two to 10. I just returned from there and I am so impressed with the build-out. It's an incredible facility and I'm very excited about our future in the Netherlands. We look forward to our first sales in Q1 2025. Now I'll turn to fresh produce, which also delivered strong sales growth despite temporary pricing pressure on the back half of the quarter. Steve's going to provide more detail, but I would like to highlight a couple of trends that set this business up for an improved second half as pricing recovers. First, our gross margin for the first six months of the year has improved by over 150 basis points, despite the pricing challenge. The underlying cost structure continues to improve and second, volumes are stronger, which will drive improved results as pricing recovers. This quarter we added more partner sales than we had and we had higher yields in our Texas operations. Both are important to maintaining the value of a fresh business with our customers and consumers to be able to share assets with our cannabis strategy. In short, we are expanding our asset-light growth strategy in fresh to supplement our cannabis plans. A question I get asked is why invest in fresh produce? The answer is simple. The business has great value as a top five North American produce marketer and the rollout of permissible cannabis in the US, either NASDAQ permitted or Texas based, is taking longer than we predicted in the last four years. Our excellence as operators stemmed from our deep cultivation expertise.

Thanks, Mike. Starting with our consolidated results, total sales grew 19% year-over-year to $92.1 million, with strong growth in both Canadian cannabis and fresh produce. The net loss was $23.5 million or $0.21 per share, compared to a net loss of $1.4 million last year. This quarter's net loss included approximately $12 million from a non-cash impairment charge on our US cannabis business, around $8.3 million related to our produce business due to poor market pricing, and $2.1 million from incentive stock compensation issued during the quarter. Consolidated adjusted EBITDA was negative $3.6 million, compared to negative $1.1 million for Q2 last year, excluding a $5.6 million settlement related to illegal matters that affected our prior period produce results. Looking at the business segment, fresh produce sales for Q2 increased 7% year-over-year to $47 million, marking our second-best quarter in the past five years. This was due to higher volumes at our Texas greenhouses and a strategic addition of third-party volume, although it was partially offset by lower pricing. Tomato pricing dropped significantly in the latter half of the quarter, leading to an unexpected operating loss, with adjusted EBITDA at negative $6.4 million. For context, prices in May and June were 31% lower than in the January to April period and 11% below our forecast. Seasonal trends usually see May-June pricing about 20% lower than the first four months. Our focus on cost efficiencies and yield expansion led to a notable improvement in our gross loss for the first half of the year. Without the additional Q2 loss from third-party supply, we would have nearly reached breakeven on gross margin for the first six months. We urge analysts and investors to assess our produce business on a full-year basis, as quarterly fluctuations and cost of sales can distort results due to our annual crop cycle. With the current pricing environment improving—partly due to seasonality and supply issues—and advancements in our cultivation technologies, including AI, we anticipate significantly better performance for fresh produce in the remainder of 2024. In Canadian cannabis, we achieved record sales in both retail branded and non-branded categories, resulting in another quarter of positive adjusted EBITDA and operating cash flow of CAD7.2 million. This cash flow supports our first Netherlands facility and the acquisition of an additional 10% ownership of rose during the quarter. Total net sales rose 45% year-over-year to CAD55.8 million, with retail branded sales growing 38% to CAD41.8 million. Non-branded sales tripled to CAD11.3 million as we capitalized on the improved B2B pricing environment to reduce inventory and generate cash. This situation presents a unique opportunity as other operators scale back production and adopt asset-light models. We will continue to leverage this as long as it benefits our branded and international sales channels, which will always be a priority. International export sales reached $2.1 million, up 11% from Q2 last year, making this the best first half of the year for ongoing international sales to date, excluding new market rollouts. We remain poised for solid year-over-year growth this year. Canadian cannabis gross margin improved to 26% from Q1; excluding low margin non-branded spec B2B sales, Q2 gross margin was 28%, thanks to a higher proportion of value brand sales. SG&A expense as a percentage of sales improved to 22% or 28%, reflecting higher sales. Adjusted EBITDA for Canadian cannabis was $6.6 million, consistent with Q2 last year. Before moving on, I want to highlight the substantial excise taxes we face as we expand our branded business. Our excise tax for Q2 amounted to CAD27 million, and CAD54 million for the first six months, representing our largest single expense. It's challenging to build a sustainable, profitable business in Canada under such a heavy tax burden. An excise tax of 30% to 40% is significant in any industry, especially a young and emerging one. Until there's a change, we'll continue to see CCAA activity in the industry, which could result in thousands of job losses or creative attempts to handle unpaid excise taxes. In the US cannabis business, Q2 sales were $4.3 million, with a gross margin of 61%. Our sales are being affected by the rise of unregulated hemp-based products, particularly synthetic ones. In response, several states are imposing strict regulations on intoxicating hemp-based products, negatively impacting our responsible GMP-produced natural hemp products sold under our CBDistillery brand. During Q2, we completed the internalization of production to enhance margin, quality, and future innovation for this preferred consumer format. We are making progress on several initiatives to boost sales and improve messaging regarding synthetic cannabinoids. Adjusted EBITDA for Q2 was negative $240,000, with a net loss of $330,000, excluding an $11.9 million intangible asset impairment, both showing improvements compared to Q1. Regarding consolidated cash flows and the balance sheet, we generated cash flow from operations of $5.7 million, up from a cash usage of $5.2 million in Q2 last year, primarily due to reduced cannabis inventory. Our finished goods cannabis inventory has decreased by 30% since the end of last year. We ended Q2 with cash of $29.7 million and working capital of $6.1 million. Total term debt at the end of Q2 was $44 million, roughly evenly divided between fresh produce maturing in May 2027 and cannabis debt due starting in February 2026. During the quarter, we amended and extended our $10 million revolving line for fresh produce, currently balanced at $4 million, maturing in May 2027. We also have a CAD15 million cannabis line of credit that’s currently undrawn. We are comfortable with our net debt level at $18.7 million. I will now turn the call back to Mike.

Hey, thanks, Steve. At the half-year mark, I'd like to close with a few thoughts before we take your questions. We are delivering on our cannabis strategy, specifically revenue growth, market share, profits and cash flow in our Canadian operations. We're in the early stages of replicating that strategy in emerging markets. Our flower is increasingly being sought out by international partners and consumers based on the reputation and success of our brands and cultivars in Canada. We are proud to participate in the Netherlands limited licensed country market, as well as Germany, the United Kingdom, and Australia and other markets as they open up. So, we've been working hard over the last four years, and we've been ready to replicate these successes in the United States, but remain quite frustrated. I really feel much stronger about what I could say here, but I've been edited back to just saying I'm frustrated. And I'm frustrated by the lack of regulatory direction, further compounded by an environment of non-enforcement, even where there are regulations. It has created a race to the bottom, and as a result, consumers, employees and an entire industry are in limbo. Conversely, it also is dividing the industry rather than uniting us. We see this currently within the hemp segment, where our subsidiary CBDistillery has developed responsible hemp-based products, yet adjacent businesses are lobbying to ban all hemp. By the way, hemp is the deregulated model that I conjecture we would all like marijuana to follow in the United States, so why are we lobbying against ourselves? At Village Farms, we believe these industries can coexist and prosper together, and that both forms of cannabis, hemp and marijuana, have their roles to play in benefiting consumers. We would welcome any other LPs or MSOs or beverage industry participants to all work together with us to speak with one voice to Federal agencies and legislatures, and at the state level as well. I'm sure we have confused lawmakers with our differences. Rather than uniting over commonalities like other industries, our door is always open to discuss this. Within Village Farms, we have strong regulatory cannabis and hemp power. If we don't unite our basic messaging, we can only hold ourselves responsible for the regulatory abyss that just ends up hurting all participants and consumers. Operator will take any calls at this point.

Thank you. Our first question will be coming from Aaron Grey of Alliance Global Partners. Your line is open, Aaron.

Hi. Good morning, and thank you for the questions. So, first question for me. I want to talk about retail branded sales. Really nice to see that growth both year-over-year and sequentially. So, wanted to say, could you give any color in terms of whether or not there was an impact, in terms of the timing of provincial boards that might have pulled forward some revenue? Or do you feel this reflects normalized purchase habits? And then on that front, have you seen a change in the buying habits from the boards amid garnishing of payments, or some of the boards just looking for LPs that can really supply quality products on a normalized basis? Thank you.

Yeah. No, I would say it's totally based on our performance quality, our innovation, our genetics. All combined is what's driving those numbers, which are pretty incredible. We feel really strong about it. It's not really tied to timing or boards. It's just pure execution at the Canadian cannabis level.

In fact, Aaron, if anything, we hit some out of stocks this quarter because we outsold our initial expectations on some of our better selling strains in particular. So, it really is just straight sales for the quarter.

Okay. Great. Thanks for that. That's great to hear on the implied velocity there. Second question for me, then, in terms of gross margins, Steve, I believe you said 28% excluding the spec impact. So just as we look going forward, how do we think about gross margin evolution historically, even saying 30% to 40% in that range? It sounds like some of the value products like Fraser Valley weighed a little bit more on margins in the quarter. So, part of that might have been higher cultivation costs. I believe you have in the season as well. So just want to get some color in terms of gross margin expectations going forward as we think about format mix both in terms of Canadian adult use as well as international and the B2B business. Thank you.

Yeah. The branded gross margin, 28% was lower due to the higher, as I said, the higher percentage of value brand. We still support the range and guidance of 30% to 40%. And we are actively analyzing our current SKU in the market.

Yeah. So, I'll add here too that we have some very strong positions in that segment right now, and that is due to the hard work by all of our teams. That is where the consumer has moved to. I think the number right now is about 34% by volume of consumers are in that price segment. And so as now a clear leader across the board, it's our job to work very carefully on profitability at that segment with our partners at the provincial boards and our retail customers.

Okay. Great. Thank you very much for the color today. I'll get back in the queue.

Thank you. Our next question will come from Eric Lauriers of Craig-Hallum Capital Group. Your line is open, Eric. Again, Eric, your line is open.

Sorry about that. I was on mute. Thank you. Thanks for taking my question and congrats on the strong performance up in Canada. My first question here is kind of a bit of a follow-on from Aaron's question. Just with the increased mix of value products, I'm just wondering what ability you have to sort of manage margins and costs there, as you were kind of touching on there at the end, Ann.

Good morning, Eric. And no problem being muted. I'm sure it's a busy morning for you. The reality is that we'll be continuing to work on this with all of our customers. We have a pretty strong discipline around the return on any of our expenditures across the company, and that includes our marketing spend. So, when we go into any discussions, we have an expectation of what that will and we monitor against that very, very closely.

All right. Great. My next question is on produce supply dynamics. Steve, you mentioned that excluding some supply loss, gross margins would have been roughly breakeven for the first half. Could you elaborate on that and also discuss the industry-wide supply issues you mentioned that may lead to improved profitability in the second half? Expanding on both of these points would be appreciated. Thank you.

What I meant by close to breakeven for our greenhouses over the full six months is that we have made considerable improvements in our volume and labor efficiencies at our Texas operations. My point about looking at the quarter-to-quarter performance can be somewhat misleading, given how we account for our production costs. The Texas crop, which begins in September and ends in June, is now complete. Looking back, costs associated with the Texas crop should have been recorded in the first quarter. However, over the entire six months, the gross margin was nearly breakeven. We also took on some additional specialty tomatoes to meet our winter contracts this upcoming season. Market prices tend to be lower in May and June due to industry supply. During the later summer months, most U.S. and Mexican growers are not active in the market, which leads to significantly better pricing in July and August. I am very confident that our performance will improve in the second half of the year compared to the second quarter.

All right. Great. Appreciate your comments. Thank you.

And our next question will come from Mike Regan of Excelsior Equities. Your line is open, Mike.

Hi, everyone. Thanks for the question. So, I guess, back on the sort of the pricing dynamics in Canada on cannabis. It sounds like a lot of the sort of price pressure and margin pressure was some mix shifts. Can you help us sort of understand how the pricing is moving on a like-for-like basis within categories in Canadian cannabis?

I can grab that one. Good question, and you're correct. I would categorize it as more of a mix shift at this point. At retail, the price per gram declines are starting to very much stabilize, slow down, flatline depending on the segment. So that's the good news. We think that the B2B business, which Steve mentioned we're participating in, is one of those leading indicators because pricing at the B2B segment has been increasing, and we think that that's got to play through to the retail as well.

Okay. Yeah. That would also make sense. I think, Mike, you know that you're seeing actual declines in supply in Canada as the taxes sort of push people out of business or they just can't make any money at this point. Is that also starting to support pricing?

I think that's one of the factors for sure. I think the other factor is the move to asset-light strategies by some players. And that's certainly helping to take out some of the biomass that might have gotten dumped into the market. And then the third factor, certainly is for those that can export. That's another market drawing down on Canadian supply.

Okay. Great. Thanks a lot.

You're welcome.

Now, our next question will be coming from Doug Cooper of Beacon Securities. Your line is open, Doug.

Hey, good morning, guys. Just a quick one on the produce side, Steve, the improved pricing or improved better environment in the second half, do you think it's enough to get you to breakeven EBITDA for the year for the produce segment?

Not for the full year. We are expecting good EBITDA in the second half, but not enough to get us back to breakeven for the full year.

Okay. Mike, switching to the Netherlands. You said you were just there. Can you give us some more color about how big you think the market is now that they move from two to 10 municipalities? How many people would be captured in those 10 municipalities? And can you walk through the sort of ramp and revenue expected? There's no excise taxes there, I'm guessing. Obviously, you don't have to sell through provincial boards and maybe just discuss what do you think the profitability would be like from that facility?

Well, I think the profitability is going to be solid. In fact, I think we can really produce some outstanding quality that is not typically found in the Netherlands market, maybe with the exception of illicit trade coming in from the United States or Canada, from what I've seen. But what's produced in the Netherlands and what comes in from other adjacent countries, that quality has never been great. So, with the cultivars we're going forward with from Canada and the cultivation facility we have in our know-how, we're expecting some really great things. Now, as far as the way the Netherlands has done it, there's not a lot of data because it's been an illicit market for 50 years, both at the cultivation and even at the coffee shop level. So, there's not a lot of data. There are numbers that talk about the market in the Netherlands. It's about a $1 billion market, but it's not substantiated. However, that's really not important for us. What's important for us is that there are 10 municipalities and about 85 coffee shops that are participating now in the legal side, and that's going to be supplied by just 10 license holders. So, we see ourselves as being immediately sold out because the capacity of the 10 license holders is just not quite enough to fulfill those 85 coffee shops to start. Secondly, as you mentioned, there is no tax. The prices in the Netherlands are far superior to anything we've seen in Canada or even the US. And the government wants to keep it that way. So, if you really look at, we take our hat off to how the Netherlands looked around, what would make the industry strong and sustainable. So, I think we'll do well there. And we're prepared to talk more about it in the first quarter of '25. We will start planting out in October, so we're only about eight weeks away, so we're on track for that. And we should be generating, for sure, revenues in the first quarter.

Okay. And just my last one, Steve, you mentioned the drop in inventories. What do you think this means? The read-through? Do you guys have to do some expansion of your Canadian facilities to keep up with demands? You guys just talked about being sold out, so maybe just talk a little bit about that.

Yeah. We are very actively looking at expanding our cultivation cannabis capacity. Obviously, as you know, we've only converted half of delta two and we are very actively looking at converting the other half. So, I'll leave you with that at this stage.

Okay. Thanks, gentlemen.

Thank you.

Operator, any questions? Tonya, we're ready for the next question.

I'm sorry. Again, our next question comes from Frederico Gomes of ATB Capital Markets. Your line is open.

Good morning. Thanks for taking my questions. Mike, just to clarify on the Netherlands, just wondering if that other operators have already started sales in the Netherlands. And if so, in that pilot program, how is that evolving?

I believe we have already begun generating revenue in the last couple of quarters, and we expect to see five to six more by the end of the year. By year-end, I anticipate that at least eight of us will be generating revenue.

Okay, perfect. Thanks for that. And then, in Canada, how sustainable do you think those market share gains that we're seeing from you guys is? I think that we've seen in the past LPs gaining share and then losing. You think that trend can continue just given the current underlying economics here, with the sector trending towards double-digit share and being sustainable with that?

Yeah. So, I think what drives it, what we've found based on our consumer insights, is innovation, quality, newness and price. And you have to drive that constantly. And as long as you're innovating and providing new strains, new products, new innovations, and you're priced right, then I think you can continue to drive, at least sustain the market share. We feel very positive we can sustain the market share, but our goal is driving. We want to drive to number one and continue to do so. So, I think, we should just look at the numbers over the last five months. It wasn't just sustaining it; it was actually increasing it. As I said in my opening remarks, we're one of the only top five that have done so. And I think that's what's driving it at the end of the day is really, you have to have products that resonate with the consumer. It's got to be a great quality every single day, and you have to innovate and provide newness, and that'll drive increased sales. So, if the market continues to grow single digits over the next three to five years, mid to high single digits, then I think we could see Canada driving to $6 billion, $7 billion at the retail level in the next three to four years. And we plan to take that share with us as we go.

And Fred, the only other thing I would add is we still have white space that we're not playing in as you look at the universe of where the consumer is. And so, we pay attention to that very closely as well as we develop our plans and our products.

Yeah. I agree with that. And we have some exciting things happening that we'll probably talk about on the next call.

Yeah. Good morning. Just to expand on that kind of white space, you continue to build brands in the different segments of the market. Pure Sun, Fraser Valley and Super Toast. Is there an area that you continue to lean in now going forward and just update? You said you might update it in the future, but update kind of addressing these different categories, kind of timing on that strategy as you look out for continuing to gain market share overall in Canada from that standpoint?

I believe we have demonstrated that our approach is to focus on becoming the top player in each market before moving on to new opportunities. We have achieved that in the flower category, being number one for the past two years. As we turn our attention to pre-rolls, we aim to secure a top two position there as well, which we have accomplished. We were cautious about expanding internationally until we were confident in our ability to be a leading player in Canada sustainably over the long term, and I believe we are at that point now. Next, we will assess which segments we are not performing well in. For instance, we want to concentrate on vapes moving forward. This strategy will guide us, as we prefer to excel in specific areas rather than spread ourselves too thin.

That makes sense. Strategy's worked out. And just a follow up on the international side, what you're seeing from Germany, kind of the opportunity, what you need to build out to continue to drive and grow that opportunity outside of the Netherlands on the international side going forward here.

Our strategy has always been to take things step by step, similar to a turtle finishing a race rather than rushing like a hare. We’ve shown success in Canada and plan to apply the same approach in Europe. Many claim they can succeed in the EU, but it’s a challenging market. This has been evident in North America as well. We are confident in our ability to make progress ahead. We value our medicinal program and position as a low-cost producer in Canada. Over time, we anticipate price reductions in the EU market, which is natural. The success we've achieved in Canada can be mirrored in Europe. Additionally, being in the Netherlands as the first recreational market provides opportunities for expansion into other markets as they open. Overall, we are optimistic about our prospects in the EU.

Regarding Germany, we are seeing an increase in inquiries and revenues as that market opens, which confirms the ongoing trend. Additionally, we successfully completed a re-certification of our EU GMP and Canadian greenhouse, and we are now in our second term with the German municipality that sponsors us.

Good morning. This is actually Mohammed Hossain. I'm on for Pablo. And we have two questions. What about your Texas produce greenhouses? Can you remind us of their scale and whether all are being utilized or some are idle? And also, please remind us what benchmarks you are using to determine the value of the Texas greenhouses.

We're not going to comment on the value since nobody really values our produce business anyway. But we're not going to comment on the values of our Texas greenhouse at this point. But all our facilities are in production with the exception of the Permian Basin, which we had reported as an asset for sale. But all the others are in full production.

Which means we have three in full production. And they're really very well detailed in our 10-K in terms of square footage and the like.

Thank you.

I could tell you that the replacement value of those assets are probably…

I am sorry. Go ahead.

And for the second question, regarding Holland, we understand some licenses already start to supply the coffee shops. Do you have a sense of how is the market performing so far, and what do you expect to start supplying the market there?

Yeah. I mean, I got to meet with a number of coffee shop owners, both in the legal ones and the current non-legal ones. And the comment I received is the quality, for the most part, is the best they've seen in Holland. So, I think it's very positive. It's early stages and probably don't want to add more color to it. But I think at this point I would say it's a positive start.

All right. Thank you for the information. You can put me back on queue.

Thank you.

I would now like to hand the call back to management for closing remarks.

Thanks, everyone. Appreciate being on the call today. And we look forward to reporting in November.

And this concludes today's conference. Thank you for your participation. You may now disconnect.